These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34316503)

  • 21. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.
    Shrwani K; Sharma R; Krishnan M; Jones T; Mayora-Neto M; Cantoni D; Temperton NJ; Dobson SL; Subramaniam K; McNamara PS; Cunliffe NA; Turtle L; Zhang Q
    J Infect Dis; 2021 Oct; 224(8):1305-1315. PubMed ID: 34161567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know.
    Rasmussen SA; Smulian JC; Lednicky JA; Wen TS; Jamieson DJ
    Am J Obstet Gynecol; 2020 May; 222(5):415-426. PubMed ID: 32105680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay.
    McDade TW; McNally EM; Zelikovich AS; D'Aquila R; Mustanski B; Miller A; Vaught LA; Reiser NL; Bogdanovic E; Fallon KS; Demonbreun AR
    PLoS One; 2020; 15(8):e0237833. PubMed ID: 32797108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit.
    Nguyen-Contant P; Embong AK; Kanagaiah P; Chaves FA; Yang H; Branche AR; Topham DJ; Sangster MY
    mBio; 2020 Sep; 11(5):. PubMed ID: 32978311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery.
    Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M
    Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2-Specific Antibody and T Cell Response Kinetics According to Symptom Severity.
    Kim JY; Kwon JS; Bae S; Cha HH; Lim JS; Kim MC; Chung JW; Park SY; Lee MJ; Kim BN; Jung J; Kim MJ; Shin EC; Kim SH
    Am J Trop Med Hyg; 2021 Jun; 105(2):395-400. PubMed ID: 34143752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 Cases.
    Castillo-Olivares J; Wells DA; Ferrari M; Chan ACY; Smith P; Nadesalingam A; Paloniemi M; Carnell GW; Ohlendorf L; Cantoni D; Mayora-Neto M; Palmer P; Tonks P; Temperton NJ; Peterhoff D; Neckermann P; Wagner R; Doffinger R; Kempster S; Otter AD; Semper A; Brooks T; Albecka A; James LC; Page M; Schwaeble W; Baxendale H; Heeney JL
    Front Immunol; 2021; 12():748291. PubMed ID: 34867975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic.
    Edlow AG; Li JZ; Collier AY; Atyeo C; James KE; Boatin AA; Gray KJ; Bordt EA; Shook LL; Yonker LM; Fasano A; Diouf K; Croul N; Devane S; Yockey LJ; Lima R; Shui J; Matute JD; Lerou PH; Akinwunmi BO; Schmidt A; Feldman J; Hauser BM; Caradonna TM; De la Flor D; D'Avino P; Regan J; Corry H; Coxen K; Fajnzylber J; Pepin D; Seaman MS; Barouch DH; Walker BD; Yu XG; Kaimal AJ; Roberts DJ; Alter G
    JAMA Netw Open; 2020 Dec; 3(12):e2030455. PubMed ID: 33351086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant-Associated Receptor Binding Domain (RBD) Mutations on the Susceptibility to Serum Antibodies Elicited by Coronavirus Disease 2019 (COVID-19) Infection or Vaccination.
    Chen LL; Lu L; Choi CY; Cai JP; Tsoi HW; Chu AW; Ip JD; Chan WM; Zhang RR; Zhang X; Tam AR; Lau DP; To WK; Que TL; Yip CC; Chan KH; Cheng VC; Yuen KY; Hung IF; To KK
    Clin Infect Dis; 2022 May; 74(9):1623-1630. PubMed ID: 34309648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Humoral Response Following 3 Doses of mRNA COVID-19 Vaccines in Patients With Non-Dialysis-Dependent CKD: An Observational Study.
    Enilama O; Yau K; Er L; Atiquzzaman M; Oliver MJ; Romney MG; Leis JA; Abe KT; Qi F; Colwill K; Gingras AC; Hladunewich MA; Levin A
    Can J Kidney Health Dis; 2024; 11():20543581231224127. PubMed ID: 38292817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seropositive Reaction Rates of 9 B-Cell Epitopes of the SARS-CoV-2 Spike Protein and the Relationship between the Epitopes and Neutralizing Antibody.
    Zhu L; Zhang Y; Yang Z; Li B; Feng T; Zou X; He J; He T; Li J; Liu N; Li W; Wang X
    Intervirology; 2022; 65(1):29-36. PubMed ID: 34233324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies' Binding Capacity Between Human Milk and Serum from Coronavirus Disease 2019-Recovered Women.
    Demers-Mathieu V; DaPra C; Medo E
    Breastfeed Med; 2021 May; 16(5):393-401. PubMed ID: 33835835
    [No Abstract]   [Full Text] [Related]  

  • 33. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Titer Levels in Pregnant Individuals After Infection, Vaccination, or Both.
    Marshall CL; Kaplowitz E; Ibroci E; Chung K; Gigase FAJ; Lieber M; Graziani M; Ohrn S; Lynch J; Castro J; Tubassum R; Mutawakil F; Jessel R; Molenaar N; Rommel AS; Sperling RS; Howell EA; Feldman H; Krammer F; Stadlbauer D; de Witte LD; Bergink V; Stone J; Janevic T; Dolan SM; Lieb W
    Obstet Gynecol; 2023 Jun; 141(6):1199-1202. PubMed ID: 37141599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study.
    Gray KJ; Bordt EA; Atyeo C; Deriso E; Akinwunmi B; Young N; Baez AM; Shook LL; Cvrk D; James K; De Guzman R; Brigida S; Diouf K; Goldfarb I; Bebell LM; Yonker LM; Fasano A; Rabi SA; Elovitz MA; Alter G; Edlow AG
    Am J Obstet Gynecol; 2021 Sep; 225(3):303.e1-303.e17. PubMed ID: 33775692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid Cytokine Release Assays for Analysis of Severe Acute Respiratory Syndrome Coronavirus 2-Specific T Cells in Whole Blood.
    Törnell A; Grauers Wiktorin H; Ringlander J; Arabpour M; Nilsson MR; Nilsson S; Kiffin R; Lindh M; Lagging M; Hellstrand K; Martner A
    J Infect Dis; 2022 Aug; 226(2):208-216. PubMed ID: 35022764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Single Dose of BNT162b2 Messenger RNA Vaccine Induces Airway Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Naive and Recovered Coronavirus Disease 2019 Subjects.
    Martinuzzi E; Benzaquen J; Guerin O; Leroy S; Simon T; Ilie M; Hofman V; Allegra M; Tanga V; Michel E; Boutros J; Maniel C; Sicard A; Glaichenhaus N; Czerkinsky C; Blancou P; Hofman P; Marquette CH
    Clin Infect Dis; 2022 Dec; 75(12):2053-2059. PubMed ID: 35579991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2.
    Ohishi T; Hishiki T; Baig MS; Rajpoot S; Saqib U; Takasaki T; Hara Y
    PLoS One; 2022; 17(7):e0271112. PubMed ID: 35830431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of IgG and neutralizing antibody responses after one or two doses of COVID-19 mRNA vaccine in previously infected and uninfected individuals.
    Demonbreun AR; Sancilio A; Velez MP; Ryan DT; Saber R; Vaught LA; Reiser NL; Hsieh RR; D'Aquila RT; Mustanski B; McNally EM; McDade TW
    EClinicalMedicine; 2021 Aug; 38():101018. PubMed ID: 34278286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-vaccination analysis of anti-spike antibody responses in kidney transplant recipients with and without COVID-19 infection in a tertiary care centre, India.
    Jasuja S; Jha V; Sagar G; Bahl A; Verma S; Jasuja N; Kaur J
    Clin Kidney J; 2022 Jul; 15(7):1312-1321. PubMed ID: 35747093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion.
    Halford S; Wan S; Dragoni I; Silvester J; Nazarov B; Anthony D; Anthony S; Ladds E; Norrie J; Dhaliwal K;
    Trials; 2021 Aug; 22(1):550. PubMed ID: 34412682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.